Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2004 Oct 11;40(1):10–21. doi: 10.1002/jnr.490400103

Effect of persistent mouse hepatitis virus infection on MHC Class I expression in murine astrocytes

J Correale 1, S Li 1, L P Weiner 1, Wendy Gilmore 1,
PMCID: PMC7167169  PMID: 7714917

Abstract

Neurotropic strains of mouse hepatitis virus (MHV) have been used extensively for the study of viral pathogenesis in the central nervous system (CNS), serving as models for human neurological diseases such as multiple sclerosis (MS). MHV strains A59 and JHMV both cause acute and chronic encephalomyelitis and demyelination in susceptible strains of mice and rats. In acute disease, CNS damage is most likely the result of lytic infection in neurons and oligodendrocytes, and death can be prevented by the adoptive transfer of Class I‐restricted CD8+ T cells. However, in later stages of the disease induced by some MHV strains, virus tends to be restricted to astrocytes in a nonlytic infection, and the immune response appears to contribute to CNS damage. These data lead us to suggest that the astrocyte may play a central role in the neuropathogenesis of MHV infection. Consistent with this possibility, A59 has been reported to induce the expression of Class I molecules of the major histocompatibility complex (MHC) in glial cells following infection in vivo and in vitro. In this communication, we have examined the influence of persistent infection by both A59 and JHMV on MHC Class I expression in primary murine astrocytes. Persistence was characterized by the presence of intracellular viral antigen and mRNA in the absence of detectable infectious virus particles. Under these conditions, JHMV, but not A59, inhibited constitutive expression of the H‐2 Kb molecule, with the magnitude of inhibition increasing with postinfection time. A59 was not able to induce Class I during persistence, presumably due to the lack of infectious virus particles. Class I expression was restored by the addition of gamma‐interferon (IFN‐γ) to astrocytes persistently infected with either A59 or JHMV. Thus, Class I inhibition is not a permanent consequence of JHMV persistence, and persistence does not interfere with normal signalling pathways for Class I induction. © 1995 Wiley‐Liss, Inc.

Keywords: astroglia, neurotropic virus, coronavirus, Class I major histocompatibility antigens, persistent infection

References

  1. Andersson M, Paabo S, Nilsson T, Peterson P (1985): Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43: 215–222. [DOI] [PubMed] [Google Scholar]
  2. Bailey OT, Pappenheimer AM, Cheever FS, Daniels JB (1949): A murine virus (JHM) causing disseminated encephalomyelitis with extensive destruction of myelin. J Exp Med 90: 195–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barker CF, Billingham RE (1977): Immunologically priviledged sites. Adv Immunol 25: 1–49. [PubMed] [Google Scholar]
  4. Beersma MFC, Bijlmakers MJE, Ploegh HL (1993): Human cytomegalovirus down‐regulates HLA class I expression by reducing the stability of class I H chains. J Immunol 151: 4455–4464. [PubMed] [Google Scholar]
  5. Berah M, Hors J, Dausset J (1970): A study of HLA antigens in human organs. Transplantation 9: 185–192. [DOI] [PubMed] [Google Scholar]
  6. Browne H, Smith G, Beck S, Minson T (1990): A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin. Nature 347: 770–772. [DOI] [PubMed] [Google Scholar]
  7. Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RL (1984): Murine hepatitis virus‐4 (strain JHM) induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132: 261–270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Burgert H‐G, Maryanski JL, Kvist S (1987): “E3/19K” protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell‐surface expression of histocompatibility class I antigens. Proc Natl Acad Sci USA 84: 1356–1360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chomcyznski P, Sacchi N (1987): Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction. Anal Biochem 162: 156–159. [DOI] [PubMed] [Google Scholar]
  10. Dubois‐Dalaq ME, Doller EW, Haspel MV, Holmes KV (1982): Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures. Virology 119: 317–331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eager KB, Williams J, Breiding D, Pan S, Knowles B, Appella E, Ricciardi RP (1985): Expression of histocompatibility antigens H‐2K, ‐D, and ‐L is reduced in adenovirus‐12‐transformed mouse cells and is restored by interferon γ. Proc Natl Acad Sci USA 82: 5525–5529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fishman PS, Gass JS, Swoverland PT (1985): Infection of the basal ganglia by a murine coronavirus. Science 229: 877–879. [DOI] [PubMed] [Google Scholar]
  13. Fleming JO, Stohlman SA, Harmon RC, Lai MMC, Frelinger JA, Weiner LP (1983): Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM (MHV‐4) virus. Virology 131: 296–307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fleming JO, Shubin RA, Sussman MA, Casteel N, Stohlman SA (1989): Monoclonal antibodies to the matrix (E1) glycoprotein of mouse hepatitis virus protect mice from encephalitis. Virology 168: 162–167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fleury HJA, Sheppard RD, Bornstein MB, Raine CS (1980): Further ultrastructural observations of virus morphogenesis and myelinpathology in JHM virus encephalomyelitis. Neuropath App Neurobiol 6: 165–179. [DOI] [PubMed] [Google Scholar]
  16. Fontana A, Erb P, Pircher H, Zinkernagel R, Weber E, Fierz W (1986): Astrocytes as antigen‐presenting cells. Part II: Unlike H‐2K‐dependent cytotoxic T cells, H‐2 Ia restricted T cells are only stimulated in the presence of interferon‐γ. J Neuroimmunol 12: 15–28. [DOI] [PubMed] [Google Scholar]
  17. Gilmore W, Fleming JO, Stohlman SA, Weiner LP (1987): Characterization of the structural proteins of the murine coronavirus strain A59 using monoclonal antibodies (42532). Proc Soc Exp Bio Med 185: 177–186. [DOI] [PubMed] [Google Scholar]
  18. Gilmore W, Fleming JOF, Moloney M, Pan E, Richardson D (1990): Reduced expression of MHC class II molecules in a murine oligodendroglioma persistently infected with the murine coronavirus, JHMV. J Cell Biochem 14F: 100. [Google Scholar]
  19. Gilmore W, Correale J., Weiner LP (1994): Coronavirus induction of class I major histocompatibility complex expression in murine astrocytes is virus strain specific. J Exp Med 180: 1013–1023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Gumbold JL, Weiss SR (1992): Mouse hepatitis virus A59 increases steady state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microb Pathogen 13: 493–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Haspel MV, Lampert PW, Oldstone MBA (1978): Temperature‐sensitive mutants of mouse hepatitis virus produce a high incidence of demyelination. Proc Natl Acad Sci 75: 4033–4036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL (1986): Immunocytochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol 19: 578–587. [DOI] [PubMed] [Google Scholar]
  23. Hickey WF, Kimura H (1988): Perivascular microglia cells of the CNS are bone‐marrow derived and present antigen in vivo. Science 239: 290–292. [DOI] [PubMed] [Google Scholar]
  24. Hirano N, Goto N, Ogawa T, Ono K, Murakami K, Fujiwara K (1980): Hydrocephalus in suckling rats infected intracerebrally with mouse hepatitis virus MHV‐A59. Microbiol Immunol 24: 825–834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton D, Merrill JE (1986): Immunoregulatory molecules and IL‐2 receptors identified in multiple sclerosis brain. J Immunol 136: 3239–3245. [PubMed] [Google Scholar]
  26. Hood L, Steinmetz M, Malissen B (1983): Gene of the major histocompatibility complex of the mouse. Ann Rev Immunol 1: 529–568. [DOI] [PubMed] [Google Scholar]
  27. Joly E, Mucke L, Oldstone MBA (1991): Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 213: 1283–1285. [DOI] [PubMed] [Google Scholar]
  28. Klein J (1986): “Natural history of the Major Histocompatibility Complex.” New York: Wiley. [Google Scholar]
  29. Knobler RL, Dubois‐Dalaq M, Haspel MV, Claysmith AP, Lampert PW, Oldstone MBA (1981): Selective localization of wild type and mutant mouse hepatitis virus (JHM strain) antigens in CNS tissue by fluorescence, light and electron microscopy. J Neuroimmunol 1: 81–92. [DOI] [PubMed] [Google Scholar]
  30. Lai MMC, Stohlman SA (1992): Molecular basis of neuropathogenicity of mouse hepatitis virus In Roos RP. (ed): “Molecular Neurovirology.” Totowa, NJ: Human Press, Inc., pp 319–347. [Google Scholar]
  31. Lavi E, Suzumura A, Hirayama M, Highkin MK, Dambach DM, Silberberg DH, Weiss SR (1987): Coronavirus mouse hepatitis virus (MHV)‐A59 causes a persistent, productive infection in primary glial cell cultures. Microbial Path 3: 79–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lavi E, Suzumura A, Murasko DM, Murray EM, Silberberg DH, Weiss SR (1988): Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. Ann NY Acad Sci; 540: 488–490. [DOI] [PubMed] [Google Scholar]
  33. Lavi E, Suzumura A, Murray EM, Silberberg DH, Weiss SR (1989): Induction of MHC class I antigens on glial cells is dependent on persistent mouse hepatitis virus infection. J Neuroimmunol 22: 107–111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lecomte J, Cainelli‐Gebara V, Mercier G, Mansour S, Talbot PJ, Lussier G, Oth D (1987): Protection from mouse hepatitis virus type 3‐induced acute disease by an anti‐nucleoprotein monoclonal antibody. Arch Virol 97: 123–130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Male DK, Pryce G, Hughes CCW (1987): Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. Immunology 60: 453–459. [PMC free article] [PubMed] [Google Scholar]
  36. Massa PT, Wege H, ter Meulen V (1986): Analysis of murine hepatitis virus (JHM strain) tropism toward Lewis rat glial cells in vitro. Type 1 astrocytes and brain macrophages (Microglia) as primary glial cell targets. Lab Invest 55: 318–327. [PubMed] [Google Scholar]
  37. Massa PT, Cowan EP, Levi B‐Z, Ozato K, McFarlin DE (1989): Genetic regulation of class I major histocompatibility complex (MHC) antigen induction on astrocytes. 24: 125–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Massa PT, Ozato K and McFarlin DE (1993): Cell type‐specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8: 201–207. [DOI] [PubMed] [Google Scholar]
  39. Maudsley J, Pound JD (1991): Modulation of MHC antigen expression by viruses and oncogenes. Immunol Today 12: 429–431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. McCarthy KD, de Vellis J (1980): Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890–902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nakanaga K, Yamanouchi K, Fujiwara K (1986): Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol. 59: 168–171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Oldstone MBA (1989): Viral persistence. Cell 56: 517–520. [DOI] [PubMed] [Google Scholar]
  43. Oldstone MBA, Sinha YN, Bount P, Tismon A, Rodriguez M, Von Wedel R, Lampert PN (1982): Virus‐induced alterations in homeostasis: Alterations in differentiated functions of infected cells in vivo. Science 218: 1125–1127. [DOI] [PubMed] [Google Scholar]
  44. Perlman S, Ries D (1987): The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb Pathogen 3: 309–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Rammensee H, Falk K, Rotzschke O (1993): Peptides naturally presented by MHC Class I molecules. Annu Rev Immunol 11: 213–244. [DOI] [PubMed] [Google Scholar]
  46. Revel M, Chebath J (1986): Interferon‐activated genes. Trend Biochem Sci 11: 166–170. [Google Scholar]
  47. Robb JA, Bond CW, Liebowitz JL (1979): Pathogenic murine coronaviruses. III. Biological and biochemical characterization of temperature‐sensitive mutants of JHMV. Virology 94: 385–399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Schnitzer J, Schachner M (1981): Expression of Thy‐1 H‐2 and NS‐4 cell surface antigens and tetanus toxin receptors in early postnatal and adult mouse cerebellum. J Neuroimmunol 1: 429–456. [DOI] [PubMed] [Google Scholar]
  49. Schrier PL, Bernards R, Vaessen RTMJ, Houweing A, van der Eb AJ (1983): Expression of class I major histocompatibility antigenes switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 305: 771–781. [DOI] [PubMed] [Google Scholar]
  50. Sedgwick JD, Robner R, Schwender S, ter Meulen V (1991): Major histocompatibility complex‐expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: Astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system. J Exp Med 173: 1235–1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Shubin RA, Sussman MA, Fleming JO, Stohlman SA (1990): Relapsing encephalomyelitis following transfer of partial immunity to JHM virus. Microb Pathogen 8: 305–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Skinner MA, Sidell SG (1983): Coronavirus JHM: Nucleotide sequence of the mRNA that encodes the nucleocapsid protein. Nucleic Acids Res 11: 5045–5054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Sorensen O, Perry D, Dales S (1980): In vivo and in vitro models of demyelinating diseases. Arch Neurol 37: 478–484. [DOI] [PubMed] [Google Scholar]
  54. Stohlman SA, Weiner LP (1981): Chronic central nervous system demyelination in mice after JHM virus infection. Neurology 31: 38–44. [DOI] [PubMed] [Google Scholar]
  55. Stohlman SA, Brayton PR, Fleming JO, Weiner LP, Lai MMC (1982): Murine coronaviruses: Isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol 63: 265–275. [DOI] [PubMed] [Google Scholar]
  56. Sussman MA, Shubin RA, Kyuwa S, Stohlman SA (1989): T‐cell‐mediated clearance of mouse hepatitis virus strain JHM from the central nervous system. J Virol 63: 3051–3056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Suzumura A, Silberberg DH, Lisak RP (1986a): The expression of MHC antigens on oligodendrocytes: Induction of polimorphic H‐2 expression by lymphokines. J Neuroimmunol 11: 179–190. [DOI] [PubMed] [Google Scholar]
  58. Suzumura A, Lavi E, Weiss SR, Silberberg DH (1986b): Coronavirus infection induces H‐2 antigen expression on oligodendrocytes and astrocytes. Nature 232: 991–993. [DOI] [PubMed] [Google Scholar]
  59. Suzumura A, Lavi E, Bhat S, Murasko D, Weiss SR, Silberberg DH (1988): Induction of glial cell MHC antigen expression in neurotropic coronavirus infections. J Immunol 140: 2068–2072. [PubMed] [Google Scholar]
  60. Traugott U, Reinherz EL, Raine CS (1982): Monoclonal anti‐T cell antibodies are applicable to the study of inflammatory infiltrates in the central nervous system. J Neuroimmunol 3: 365–373. [DOI] [PubMed] [Google Scholar]
  61. van Berlo MF, Wolswijk G, Calafat J, Koolen MJM, Horzinek MC, van der Zeijst BAM (1986): Restricted replication of mouse hepatitis virus A59 in primary mouse brain astrocytes correlates with reduced pathogenicity. J Virol 58: 426–433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. van Berlo MF, Warringa R, Wolswijk G, Lopes‐Cardozo (1989): Vulnerability of rat and mouse brain cells to murine hepatitis virus (JHM‐strain): Studies in vivo and in vitro. Glia 2: 85–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Wang F‐I, Hinton DR, Gilmore W, Trousdale MD, Fleming JO (1992): Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV‐4) leads to a characteristic distribution of demyelination. Lab Invest 66: 744–754. [PubMed] [Google Scholar]
  64. Wege H, Watanabe R, ter Meulen V (1984): Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection. J Neuroimmunol 6: 325–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Weiner LP (1973): Pathogenesis of demyelination induced by a mouse hepatitis virus (JHM virus). Arch Neurol 28: 298–303. [DOI] [PubMed] [Google Scholar]
  66. Williamson JSP, Stohlman SA (1990): Effective clearance of mouse hepatitis virus from the central nervous system requires both CD4+ and CD8+ T cells. J Virol 64: 4589–4592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Williamson JSP, Sykes KC, Stohlman SA (1991): Characterization of brain‐infiltrating mononuclear cells during infection with mouse hepatitis virus strain JHM. J Neuroimmunol 32: 199–207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Wong GHW, Bartlett PF, Clark‐Lewis I, Battye F, Schrader JW (1984): Inducible expression of H‐2 and Ia antigens on brain cells. Nature 310: 688–691. [DOI] [PubMed] [Google Scholar]
  69. Wong GHW, Bartlett PF, Clark‐Lewis I, McKimm‐Breschkin JL, Schrader JW (1985): Interferon‐γ induces the expression of H‐2 and Ia antigens on brain cells. J Neuroimmunol 7: 255–278. [DOI] [PubMed] [Google Scholar]
  70. Yamaguchi K, Goto N, Kyuwa S, Hayami M, Toyoda Y (1991): Protection of mice from a lethal coronavirus infection in the central nervous system by adoptive transfer of virus‐specific T cell clones. J Neuroimmunol 32: 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Yewdell JW, Bennink JR (1992): Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule‐restricted T lymphocytes. Adv Immunol 52: 1–123. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neuroscience Research are provided here courtesy of Wiley

RESOURCES